Chronic myelocytic leukemia: development of conditioning regimens for marrow transplantation.
Storb
R
R
Fred Hutchinson Cancer Research Center, Seattle, Washington.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D016026:Bone Marrow Transplantation / Q000379:methods*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004064:Digestive System / Q000528:radiation effects; D004285:Dogs; D006086:Graft vs Host Disease / Q000517:prevention & control; D006648:Histocompatibility; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery*; D017493:Leukocyte Common Antigens / Q000276:immunology; D011300:Preoperative Care; D011879:Radiotherapy Dosage; D014916:Whole-Body Irradiation
D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes; D003520:Cyclophosphamide; D017493:Leukocyte Common Antigens